Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Digoxin In NASH (CODIN) — Stella

Home/NASH/Digoxin In NASH (CODIN)

View on ClinicalTrials.gov

Recruiting

Back to NASH trials

Digoxin In NASH (CODIN)

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(2 sites)

United States

Yale New Haven Health, New Haven, Connecticut

Yale New Haven Hospital, New Haven, Connecticut

Key details

Phase

Safety & dosing

Sponsor

Yale University

Collaborators

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Enrollment target

~144 participants

Started

June 2025

Primary completion

January 2029

Age range

18 Years – 75 Years

Last updated October 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.